Simva B tablets (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Withus Pharmaceuticals Co., Ltd.
MFDS item code 202001928 · Approved 2020.03.19
This product's status changed to Expired on 2025.03.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hyperlipidemia (including heterozygous familial hypercholesterolemia in children) and prevention of cardiovascular disease
This medication is effective in reducing various risks related to cardiovascular disease. It decreases the risk of death from coronary artery disease, non-fatal myocardial infarction, and stroke in adult patients at high risk of cardiovascular events, such as those with coronary artery disease, diabetes, peripheral vascular disease, and stroke. It also reduces the risk of coronary and non-coronary vascular reconstruction. In patients with hyperlipidemia, it is used as an adjunct therapy to lower total cholesterol, LDL-cholesterol, apolipoprotein B, and triglyceride levels while increasing HDL-cholesterol. It is particularly helpful for patients with genetic dyslipidemia, such as familial hypercholesterolemia. It is also used in children aged 10 to 17 years with heterozygous familial hypercholesterolemia to assist dietary efforts in lowering cholesterol levels. Overall, this drug is used to reduce the risk of cardiovascular disease and improve dyslipidemia.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia As the usual initial dose, 20 mg of this medicine once daily in the evening is recommended. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. Administration of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate according to the initial LDL-cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Controlled clinical trial results indicate that patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. This medicine should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not possible. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered to patients taking verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered to patients taking amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Coadministration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients Who Must Not Take This Medicine under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Use in patients with renal impairment Because this medicine is not excreted extensively by the kidneys, dose adjustment is not necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor carefully.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, with a maximum recommended dose of 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This medication can cause serious muscle-related side effects such as myopathy and rhabdomyolysis, especially when taking a high dose of 80 mg. Therefore, patients taking this medication at 80 mg are advised to switch to a lower dose or a different safer statin when taking interacting medications. Patients with allergies to this medication, those with active liver disease, pregnant or nursing women, and those taking certain strong medications should not use this drug. Additionally, patients with genetic issues like lactose intolerance should also avoid this medication. Patients with compromised liver or kidney function, alcohol addiction, hypothyroidism, a history of muscle disease, elderly patients, and women should use this medication with caution, and special care is needed for those with allergies to certain dyes. While taking this medication, side effects such as muscle pain, muscle weakness, abdominal pain, headache, constipation, diarrhea, and nausea may occur, and rare cases of serious muscle damage can happen. If muscle pain or weakness occurs, the doctor should be notified immediately, and the medication should be discontinued if necessary. Liver function abnormalities may also occur, so routine liver function tests should be performed, and the medication should be stopped immediately if symptoms of hepatitis or jaundice occur. This medication can interact with multiple other drugs, so it is essential to inform the doctor or pharmacist of any other medications being taken, especially when combined with certain antibiotics, antifungals, immunosuppressants, calcium channel blockers, niacin, or fusidic acid, as dose adjustments or monitoring may be necessary. Pregnant women or those who might become pregnant should avoid taking this medication and should immediately stop if pregnancy is confirmed. Nursing is also not recommended while taking this medication, thus breastfeeding should be ceased. This drug should not be used in children under 10 or pre-menarchal females and should only be used in limited doses in patients aged 10 to 17. Elderly patients should be cautious as the blood concentration of this drug may increase, increasing the risk of muscle-related side effects. Patients taking this medication should closely watch for muscle-related symptoms and signs of liver function abnormalities, and consult healthcare professionals immediately if any suspicious symptoms arise. Lastly, this medication should be kept out of reach of children, stored in its original container, and beverages that significantly inhibit CYP3A4 enzymes, such as grapefruit juice, should not be consumed in large quantities.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering, and it is best kept at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the effect of the medication for a long time.
Yellow-brown oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Simvastatin 20mg
Tablet · Prescription medication
Withus Pharmaceuticals Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.